Pharmaceutical Technology2m
GSK eyes up combo approval for previously withdrawn myeloma drug
The US Food and Drug Administration (FDA) is expected to make a Prescription Drug User Fee Act (PDUFA) decision by mid-2025.
Pharmaceutical Technology57m
MSD’s WELIREG approved by NMPA to treat VHL disease-associated tumours
China’s NMPA has approved MSD’s WELIREG (belzutifan) to treat adult individuals with certain types of VHL disease-associated ...
Pharmaceutical Technology2h
Exploring drug shortages in european markets: the causes, analysis, and response
Since 2023, the pharmaceutical industry operating in Europe has faced an unprecedented challenge related to drug shortages.
Pharmaceutical Technology3h
FDA approves BridgeBio’s Attruby for ATTR-CM treatment
The US Food and Drug Administration (FDA) has approved BridgeBio Pharma ’s Attruby (acoramidis), an oral transthyretin (TTR) ...